In the present meta‐analysis, the correlations between ezrin expression and prognostic and clinicopathological outcomes (CP) were evaluated to investigate whether ezrin expression could serve as a prognostic and clinicopathological biomarker for patients with bone and soft tissue sarcomas. This evidence concerns the gene EZR and soft tissue sarcoma.